相似文献
1
Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.
J Infect Dis. 2006 Mar 1;193(5):625-33. doi: 10.1086/500148. Epub 2006 Feb 2.
2
Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.
Infect Immun. 2009 Sep;77(9):3902-8. doi: 10.1128/IAI.00200-09. Epub 2009 Jun 15.
3
Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
Mol Immunol. 2007 Apr;44(10):2749-55. doi: 10.1016/j.molimm.2006.11.011. Epub 2007 Jan 8.
4
Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
Infect Immun. 2009 Nov;77(11):4859-67. doi: 10.1128/IAI.00117-09. Epub 2009 Aug 24.
5
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.
Antimicrob Agents Chemother. 2007 Aug;51(8):2758-64. doi: 10.1128/AAC.01528-06. Epub 2007 May 21.
6
Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Infect Immun. 2009 Jan;77(1):162-9. doi: 10.1128/IAI.00788-08. Epub 2008 Nov 3.
7
In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
Infect Immun. 2007 Nov;75(11):5443-52. doi: 10.1128/IAI.00529-07. Epub 2007 Aug 20.
8
The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
Biochem Biophys Res Commun. 2009 Aug 7;385(4):591-5. doi: 10.1016/j.bbrc.2009.05.114. Epub 2009 May 30.
9
Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
Infect Immun. 2013 Jun;81(6):1880-8. doi: 10.1128/IAI.01328-12. Epub 2013 Mar 18.
10
Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
Toxins (Basel). 2011 Aug;3(8):979-90. doi: 10.3390/toxins3080979. Epub 2011 Aug 9.
引用本文的文献
1
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants.
Cell Rep. 2022 Nov 1;41(5):111528. doi: 10.1016/j.celrep.2022.111528. Epub 2022 Sep 30.
2
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside.
Toxins (Basel). 2022 Feb 25;14(3):172. doi: 10.3390/toxins14030172.
3
Characterization of the adaptive immune response of donors receiving live anthrax vaccine.
PLoS One. 2021 Dec 20;16(12):e0260202. doi: 10.1371/journal.pone.0260202. eCollection 2021.
4
On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions.
Int J Mol Sci. 2021 Jun 21;22(12):6616. doi: 10.3390/ijms22126616.
5
Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
BMC Infect Dis. 2018 Dec 10;18(1):640. doi: 10.1186/s12879-018-3542-6.
6
Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries.
Adv Exp Med Biol. 2017;1053:99-117. doi: 10.1007/978-3-319-72077-7_6.
7
Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin.
Braz J Microbiol. 2017 Jul-Sep;48(3):570-575. doi: 10.1016/j.bjm.2016.10.023. Epub 2017 Feb 3.
8
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation.
Genome Med. 2016 Apr 13;8(1):39. doi: 10.1186/s13073-016-0294-z.
9
A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax.
Sci Rep. 2015 Jul 2;5:11776. doi: 10.1038/srep11776.
10
Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.
Clin Vaccine Immunol. 2015 Aug;22(8):902-8. doi: 10.1128/CVI.00137-15. Epub 2015 Jun 3.
本文引用的文献
1
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Infect Immun. 2005 Feb;73(2):795-802. doi: 10.1128/IAI.73.2.795-802.2005.
2
Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
Infect Immun. 2004 Nov;72(11):6313-7. doi: 10.1128/IAI.72.11.6313-6317.2004.
3
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.
J Immune Based Ther Vaccines. 2004 May 12;2(1):5. doi: 10.1186/1476-8518-2-5.
4
Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine.
Vaccine. 2003 Dec 12;22(2):257-67. doi: 10.1016/j.vaccine.2003.07.008.
5
Anthrax toxin.
Annu Rev Cell Dev Biol. 2003;19:45-70. doi: 10.1146/annurev.cellbio.19.111301.140655.
6
Human antibodies from immunized donors are protective against anthrax toxin in vivo.
Nat Biotechnol. 2003 Nov;21(11):1305-6. doi: 10.1038/nbt891. Epub 2003 Oct 12.
7
Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody.
J Biol Chem. 2003 Aug 15;278(33):30936-44. doi: 10.1074/jbc.M301154200. Epub 2003 May 27.
8
Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria.
Biophys J. 2003 Jun;84(6):4062-77. doi: 10.1016/S0006-3495(03)75132-7.
9
Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
J Biol Chem. 2003 Feb 14;278(7):5227-34. doi: 10.1074/jbc.M210321200. Epub 2002 Dec 4.
10
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
Nat Biotechnol. 2002 Jun;20(6):597-601. doi: 10.1038/nbt0602-597.
Zotero 插件